| 0 |
PNEUMONIA SERRATIA |
1 |
0.0217 |
| 1 |
PELVIC BONE INJURY |
1 |
0.0115 |
| 2 |
SELF ESTEEM INFLATED |
1 |
0.0078 |
| 3 |
COR PULMONALE CHRONIC |
1 |
0.0053 |
| 4 |
ORAL CONTUSION |
1 |
0.0043 |
| 5 |
FROSTBITE |
1 |
0.0033 |
| 6 |
POST PROCEDURAL CONTUSION |
1 |
0.0030 |
| 7 |
ILEOSTOMY CLOSURE |
1 |
0.0030 |
| 8 |
ANAPHYLACTOID SHOCK |
1 |
0.0021 |
| 9 |
CSF TEST ABNORMAL |
1 |
0.0020 |
| 10 |
APPLICATION SITE INFECTION |
1 |
0.0020 |
| 11 |
SACRAL PAIN |
1 |
0.0016 |
| 12 |
APPLICATION SITE ULCER |
1 |
0.0014 |
| 13 |
INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION |
1 |
0.0013 |
| 14 |
OESOPHAGEAL RUPTURE |
1 |
0.0012 |
| 15 |
DEVICE LOOSENING |
1 |
0.0012 |
| 16 |
EYE COLOUR CHANGE |
1 |
0.0010 |
| 17 |
PERTUSSIS |
1 |
0.0010 |
| 18 |
URETEROLITHIASIS |
1 |
0.0010 |
| 19 |
APPLICATION SITE DISCHARGE |
1 |
0.0009 |
| 20 |
PRURITUS ALLERGIC |
1 |
0.0009 |
| 21 |
ESCHERICHIA TEST POSITIVE |
1 |
0.0008 |
| 22 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 23 |
BLADDER DISCOMFORT |
1 |
0.0008 |
| 24 |
APPLICATION SITE SCAR |
1 |
0.0008 |
| 25 |
RHONCHI |
1 |
0.0007 |
| 26 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 27 |
NASAL ULCER |
1 |
0.0006 |
| 28 |
PULMONARY ARTERIAL PRESSURE INCREASED |
1 |
0.0006 |
| 29 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 30 |
SKIN WOUND |
1 |
0.0006 |
| 31 |
APPLICATION SITE DISCOMFORT |
1 |
0.0006 |
| 32 |
TUNNEL VISION |
1 |
0.0005 |
| 33 |
PNEUMONIA FUNGAL |
2 |
0.0005 |
| 34 |
DILATATION VENTRICULAR |
1 |
0.0005 |
| 35 |
VOLVULUS |
1 |
0.0004 |
| 36 |
WRONG DOSE |
1 |
0.0004 |
| 37 |
SKIN FRAGILITY |
1 |
0.0004 |
| 38 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 39 |
PLEURITIC PAIN |
1 |
0.0004 |
| 40 |
CHOLECYSTITIS INFECTIVE |
1 |
0.0004 |
| 41 |
CREPITATIONS |
1 |
0.0003 |
| 42 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 43 |
BACTERIAL SEPSIS |
1 |
0.0003 |
| 44 |
PRODUCT LABEL ISSUE |
2 |
0.0003 |
| 45 |
EAR PRURITUS |
1 |
0.0003 |
| 46 |
SEASONAL ALLERGY |
4 |
0.0003 |
| 47 |
FACIAL BONES FRACTURE |
1 |
0.0003 |
| 48 |
SKIN LACERATION |
3 |
0.0003 |
| 49 |
ORAL INFECTION |
1 |
0.0003 |
| 50 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 51 |
APPLICATION SITE EXFOLIATION |
1 |
0.0002 |
| 52 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 53 |
LEFT VENTRICULAR HYPERTROPHY |
1 |
0.0002 |
| 54 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 55 |
BLOOD CHOLESTEROL ABNORMAL |
1 |
0.0002 |
| 56 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 57 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 58 |
HYPERVOLAEMIA |
1 |
0.0002 |
| 59 |
DIABETIC NEUROPATHY |
1 |
0.0002 |
| 60 |
APPLICATION SITE SWELLING |
1 |
0.0002 |
| 61 |
FOLLICULITIS |
2 |
0.0002 |
| 62 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 63 |
GINGIVITIS |
1 |
0.0002 |
| 64 |
FAECALOMA |
1 |
0.0002 |
| 65 |
SKIN ATROPHY |
1 |
0.0002 |
| 66 |
LEFT VENTRICULAR DYSFUNCTION |
1 |
0.0001 |
| 67 |
FULL BLOOD COUNT DECREASED |
3 |
0.0001 |
| 68 |
BRONCHIECTASIS |
1 |
0.0001 |
| 69 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 70 |
PULMONARY HYPERTENSION |
3 |
0.0001 |
| 71 |
APHONIA |
2 |
0.0001 |
| 72 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 73 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 74 |
BLOOD PRESSURE DIASTOLIC DECREASED |
1 |
0.0001 |
| 75 |
ARTHROPOD BITE |
1 |
0.0001 |
| 76 |
DEVICE PHYSICAL PROPERTY ISSUE |
1 |
0.0001 |
| 77 |
LIPASE INCREASED |
1 |
0.0001 |
| 78 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 79 |
MUSCLE TIGHTNESS |
2 |
0.0001 |
| 80 |
ASPHYXIA |
1 |
0.0001 |
| 81 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 82 |
BLOOD MAGNESIUM DECREASED |
1 |
0.0001 |
| 83 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 84 |
PERSONALITY CHANGE |
1 |
0.0001 |
| 85 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 86 |
HOSPICE CARE |
1 |
0.0001 |
| 87 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 88 |
SKIN INFECTION |
1 |
0.0001 |
| 89 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 90 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 91 |
SPINAL PAIN |
1 |
0.0001 |
| 92 |
SEXUAL DYSFUNCTION |
1 |
0.0001 |
| 93 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 94 |
ACCIDENT |
1 |
0.0001 |
| 95 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 96 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 97 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 98 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 99 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 100 |
HIATUS HERNIA |
1 |
0.0001 |
| 101 |
EXPOSURE VIA SKIN CONTACT |
2 |
0.0001 |
| 102 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 103 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 104 |
SINUS CONGESTION |
1 |
0.0001 |
| 105 |
LIMB INJURY |
2 |
0.0001 |
| 106 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 107 |
APPLICATION SITE RASH |
1 |
0.0001 |
| 108 |
HUNGER |
1 |
0.0001 |
| 109 |
DEVICE OCCLUSION |
1 |
0.0001 |
| 110 |
ANOSMIA |
1 |
0.0001 |
| 111 |
THYROID DISORDER |
1 |
0.0001 |
| 112 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 113 |
HEAD INJURY |
2 |
0.0001 |
| 114 |
PNEUMOTHORAX |
1 |
0.0001 |
| 115 |
BACK DISORDER |
1 |
0.0001 |
| 116 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 117 |
SCAR |
1 |
0.0001 |
| 118 |
SYRINGE ISSUE |
1 |
0.0001 |
| 119 |
HEART RATE DECREASED |
2 |
0.0001 |
| 120 |
COLD SWEAT |
1 |
0.0001 |
| 121 |
GOUT |
1 |
0.0001 |
| 122 |
DYSPHAGIA |
5 |
0.0001 |
| 123 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 124 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 125 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 126 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 127 |
DERMATITIS |
1 |
0.0000 |
| 128 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 129 |
ALTERED STATE OF CONSCIOUSNESS |
1 |
0.0000 |
| 130 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 131 |
ORAL PAIN |
1 |
0.0000 |
| 132 |
SNEEZING |
1 |
0.0000 |
| 133 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 134 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 135 |
MULTIPLE SCLEROSIS |
2 |
0.0000 |
| 136 |
BLOOD GLUCOSE DECREASED |
2 |
0.0000 |
| 137 |
LOCALISED INFECTION |
1 |
0.0000 |
| 138 |
PRESYNCOPE |
1 |
0.0000 |
| 139 |
AGEUSIA |
1 |
0.0000 |
| 140 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 141 |
HYPOPHAGIA |
1 |
0.0000 |
| 142 |
HAEMATOMA |
1 |
0.0000 |
| 143 |
EAR INFECTION |
1 |
0.0000 |
| 144 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 145 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 146 |
NECK PAIN |
2 |
0.0000 |
| 147 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 148 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 149 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 150 |
LETHARGY |
2 |
0.0000 |
| 151 |
NEEDLE ISSUE |
1 |
0.0000 |
| 152 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 153 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 154 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 155 |
CYSTITIS |
1 |
0.0000 |
| 156 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 157 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 158 |
VIRAL INFECTION |
1 |
0.0000 |
| 159 |
SINUSITIS |
3 |
0.0000 |
| 160 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
2 |
0.0000 |
| 161 |
CONSTIPATION |
6 |
0.0000 |
| 162 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 163 |
DYSURIA |
1 |
0.0000 |
| 164 |
BRONCHITIS |
2 |
0.0000 |
| 165 |
DYSGEUSIA |
2 |
0.0000 |
| 166 |
DECREASED APPETITE |
6 |
0.0000 |
| 167 |
CHILLS |
3 |
0.0000 |
| 168 |
DISORIENTATION |
1 |
0.0000 |
| 169 |
WEIGHT DECREASED |
7 |
0.0000 |
| 170 |
DEVICE BREAKAGE |
1 |
0.0000 |
| 171 |
OSTEOPOROSIS |
1 |
0.0000 |
| 172 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 173 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 174 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 175 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 176 |
SEPTIC SHOCK |
1 |
0.0000 |
| 177 |
MENTAL DISORDER |
1 |
0.0000 |
| 178 |
DRUG WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 179 |
DRY SKIN |
3 |
0.0000 |
| 180 |
GASTROINTESTINAL DISORDER |
2 |
0.0000 |
| 181 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 182 |
ADVERSE EVENT |
2 |
0.0000 |
| 183 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 184 |
PNEUMONIA |
7 |
0.0000 |
| 185 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 186 |
MIGRAINE |
2 |
0.0000 |
| 187 |
PRODUCTIVE COUGH |
1 |
0.0000 |
| 188 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 189 |
SOMNOLENCE |
4 |
0.0000 |
| 190 |
CELLULITIS |
1 |
0.0000 |
| 191 |
ABDOMINAL PAIN UPPER |
4 |
0.0000 |
| 192 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 193 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 194 |
ECZEMA |
1 |
0.0000 |
| 195 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 196 |
SPEECH DISORDER |
1 |
0.0000 |
| 197 |
BRADYCARDIA |
1 |
0.0000 |
| 198 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 199 |
OEDEMA |
1 |
0.0000 |
| 200 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 201 |
INFLUENZA |
2 |
0.0000 |
| 202 |
SEPSIS |
2 |
0.0000 |
| 203 |
BLISTER |
1 |
0.0000 |
| 204 |
FLATULENCE |
1 |
0.0000 |
| 205 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 206 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 207 |
CONVULSION |
1 |
0.0000 |
| 208 |
HERPES ZOSTER |
1 |
0.0000 |
| 209 |
EYE IRRITATION |
1 |
0.0000 |
| 210 |
SEIZURE |
2 |
0.0000 |
| 211 |
COVID-19 |
3 |
0.0000 |
| 212 |
BONE PAIN |
1 |
0.0000 |
| 213 |
SURGERY |
1 |
0.0000 |
| 214 |
WHEEZING |
1 |
0.0000 |
| 215 |
IRRITABILITY |
1 |
0.0000 |
| 216 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 217 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 218 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 219 |
FEELING HOT |
1 |
0.0000 |
| 220 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 221 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 222 |
PRURITUS |
6 |
0.0000 |
| 223 |
HYPERHIDROSIS |
2 |
0.0000 |
| 224 |
SWELLING FACE |
1 |
0.0000 |
| 225 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 226 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 227 |
FALL |
5 |
0.0000 |
| 228 |
DEHYDRATION |
2 |
0.0000 |
| 229 |
HYPOTENSION |
3 |
0.0000 |
| 230 |
PRODUCT QUALITY ISSUE |
2 |
0.0000 |
| 231 |
ERYTHEMA |
3 |
0.0000 |
| 232 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 233 |
RASH |
6 |
0.0000 |
| 234 |
AGITATION |
1 |
0.0000 |
| 235 |
PRODUCT DOSE OMISSION ISSUE |
4 |
0.0000 |
| 236 |
EPISTAXIS |
1 |
0.0000 |
| 237 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 238 |
DEPRESSION |
3 |
0.0000 |
| 239 |
DIABETES MELLITUS |
1 |
0.0000 |
| 240 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 241 |
BACK PAIN |
3 |
0.0000 |
| 242 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 243 |
DYSPNOEA |
7 |
0.0000 |
| 244 |
DRY MOUTH |
1 |
0.0000 |
| 245 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 246 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 247 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 248 |
TOXICITY TO VARIOUS AGENTS |
2 |
0.0000 |
| 249 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 250 |
BALANCE DISORDER |
1 |
0.0000 |
| 251 |
MALAISE |
5 |
0.0000 |
| 252 |
INSOMNIA |
3 |
0.0000 |
| 253 |
TACHYCARDIA |
1 |
0.0000 |
| 254 |
DEVICE ISSUE |
1 |
0.0000 |
| 255 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 256 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 257 |
COUGH |
3 |
0.0000 |
| 258 |
SWELLING |
1 |
0.0000 |
| 259 |
ASTHENIA |
4 |
0.0000 |
| 260 |
CONTUSION |
1 |
0.0000 |
| 261 |
CONDITION AGGRAVATED |
3 |
0.0000 |
| 262 |
ILLNESS |
1 |
0.0000 |
| 263 |
HYPERTENSION |
2 |
0.0000 |
| 264 |
DIARRHOEA |
6 |
0.0000 |
| 265 |
FATIGUE |
7 |
0.0000 |
| 266 |
WEIGHT INCREASED |
2 |
0.0000 |
| 267 |
ASTHMA |
1 |
0.0000 |
| 268 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 269 |
PALPITATIONS |
1 |
0.0000 |
| 270 |
JOINT SWELLING |
1 |
0.0000 |
| 271 |
PAIN |
5 |
0.0000 |
| 272 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 273 |
OFF LABEL USE |
7 |
0.0000 |
| 274 |
NAUSEA |
6 |
0.0000 |
| 275 |
ANXIETY |
2 |
0.0000 |
| 276 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 277 |
PAIN IN EXTREMITY |
2 |
0.0000 |
| 278 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 279 |
HOSPITALISATION |
1 |
0.0000 |
| 280 |
HEADACHE |
4 |
0.0000 |
| 281 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 282 |
TREMOR |
1 |
0.0000 |
| 283 |
URTICARIA |
1 |
0.0000 |
| 284 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 285 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 286 |
MYALGIA |
1 |
0.0000 |
| 287 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 288 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 289 |
ALOPECIA |
1 |
0.0000 |
| 290 |
DEATH |
4 |
0.0000 |
| 291 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 292 |
FEELING ABNORMAL |
1 |
0.0000 |
| 293 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 294 |
DIZZINESS |
2 |
0.0000 |
| 295 |
ARTHRALGIA |
1 |
0.0000 |
| 296 |
VOMITING |
1 |
0.0000 |